209 related articles for article (PubMed ID: 21070126)
1. A novel BMPR2 gene mutation associated with exercise-induced pulmonary hypertension in septal defects.
Möller T; Leren TP; Eiklid KL; Holmstrøm H; Fredriksen PM; Thaulow E
Scand Cardiovasc J; 2010 Dec; 44(6):331-6. PubMed ID: 21070126
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in a Polish population of patients with pulmonary arterial hypertension: sequencing of BMPR2, ALK1, and ENG genes.
Uznańska-Loch B; Wikło K; Kulczycka-Wojdala D; Szymańska B; Chrzanowski Ł; Wierzbowska-Drabik K; Trzos E; Kasprzak JD; Kurpesa M
Kardiol Pol; 2018; 76(5):852-859. PubMed ID: 29350394
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood.
Harrison RE; Berger R; Haworth SG; Tulloh R; Mache CJ; Morrell NW; Aldred MA; Trembath RC
Circulation; 2005 Feb; 111(4):435-41. PubMed ID: 15687131
[TBL] [Abstract][Full Text] [Related]
4. Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
van der Bruggen CE; Happé CM; Dorfmüller P; Trip P; Spruijt OA; Rol N; Hoevenaars FP; Houweling AC; Girerd B; Marcus JT; Mercier O; Humbert M; Handoko ML; van der Velden J; Vonk Noordegraaf A; Bogaard HJ; Goumans MJ; de Man FS
Circulation; 2016 May; 133(18):1747-60. PubMed ID: 26984938
[TBL] [Abstract][Full Text] [Related]
5. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.
Fujiwara M; Yagi H; Matsuoka R; Akimoto K; Furutani M; Imamura S; Uehara R; Nakayama T; Takao A; Nakazawa M; Saji T
Circ J; 2008 Jan; 72(1):127-33. PubMed ID: 18159113
[TBL] [Abstract][Full Text] [Related]
6. Genetic counselling in a national referral centre for pulmonary hypertension.
Girerd B; Montani D; Jaïs X; Eyries M; Yaici A; Sztrymf B; Savale L; Parent F; Coulet F; Godinas L; Lau EM; Tamura Y; Sitbon O; Soubrier F; Simonneau G; Humbert M
Eur Respir J; 2016 Feb; 47(2):541-52. PubMed ID: 26699722
[TBL] [Abstract][Full Text] [Related]
7. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease.
Roberts KE; McElroy JJ; Wong WP; Yen E; Widlitz A; Barst RJ; Knowles JA; Morse JH
Eur Respir J; 2004 Sep; 24(3):371-4. PubMed ID: 15358693
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension.
Pfarr N; Fischer C; Ehlken N; Becker-Grünig T; López-González V; Gorenflo M; Hager A; Hinderhofer K; Miera O; Nagel C; Schranz D; Grünig E
Respir Res; 2013 Jan; 14(1):3. PubMed ID: 23298310
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
[TBL] [Abstract][Full Text] [Related]
11. Mutation in BMPR2 Promoter: A 'Second Hit' for Manifestation of Pulmonary Arterial Hypertension?
Viales RR; Eichstaedt CA; Ehlken N; Fischer C; Lichtblau M; Grünig E; Hinderhofer K
PLoS One; 2015; 10(7):e0133042. PubMed ID: 26167679
[TBL] [Abstract][Full Text] [Related]
12. Identification of a new intronic BMPR2-mutation and early diagnosis of heritable pulmonary arterial hypertension in a large family with mean clinical follow-up of 12 years.
Hinderhofer K; Fischer C; Pfarr N; Szamalek-Hoegel J; Lichtblau M; Nagel C; Egenlauf B; Ehlken N; Grünig E
PLoS One; 2014; 9(3):e91374. PubMed ID: 24621962
[TBL] [Abstract][Full Text] [Related]
13. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
Feng F; Harper RL; Reynolds PN
Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic characteristics of Chinese patients with hereditary haemorrhagic telangiectasia-associated pulmonary hypertension.
Chen YJ; Yang QH; Liu D; Liu QQ; Eyries M; Wen L; Wu WH; Jiang X; Yuan P; Zhang R; Soubrier F; Jing ZC
Eur J Clin Invest; 2013 Oct; 43(10):1016-24. PubMed ID: 23919827
[TBL] [Abstract][Full Text] [Related]
15. The Efficacy of a Genetic Analysis of the BMPR2 Gene in a Patient with Severe Pulmonary Arterial Hypertension and an Atrial Septal Defect Treated with Bilateral Lung Transplantation.
Tatebe S; Sugimura K; Aoki T; Yamamoto S; Yaoita N; Suzuki H; Sato H; Kozu K; Konno R; Satoh K; Fukuda K; Adachi O; Saito R; Nakanishi N; Morisaki H; Oyama K; Saiki Y; Okada Y; Shimokawa H
Intern Med; 2017 Dec; 56(23):3193-3197. PubMed ID: 29021450
[TBL] [Abstract][Full Text] [Related]
16. [Genetic, cellular and molecular mechanisms of pulmonary arterial hypertension].
Alan B; Nalbantgil S
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():9-13. PubMed ID: 20819762
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary arterial hypertension and portal hypertension in a patient with hereditary hemorrhagic telangiectasia.
Pousada G; Baloira A; Valverde D
Med Clin (Barc); 2015 Mar; 144(6):261-4. PubMed ID: 25543221
[TBL] [Abstract][Full Text] [Related]
18. Eisenmenger syndrome and atrial septal defect: nature or nurture?
Therrien J; Rambihar S; Newman B; Siminovitch K; Langleben D; Webb G; Granton J
Can J Cardiol; 2006 Nov; 22(13):1133-6. PubMed ID: 17102831
[TBL] [Abstract][Full Text] [Related]
19. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.
Harrison RE; Flanagan JA; Sankelo M; Abdalla SA; Rowell J; Machado RD; Elliott CG; Robbins IM; Olschewski H; McLaughlin V; Gruenig E; Kermeen F; Halme M; Räisänen-Sokolowski A; Laitinen T; Morrell NW; Trembath RC
J Med Genet; 2003 Dec; 40(12):865-71. PubMed ID: 14684682
[TBL] [Abstract][Full Text] [Related]
20. Right ventricular and pulmonary vascular reserve in asymptomatic BMPR2 mutation carriers.
Claessen G; La Gerche A; Petit T; Gillijns H; Bogaert J; Claeys M; Dymarkowski S; Claus P; Delcroix M; Heidbuchel H
J Heart Lung Transplant; 2017 Feb; 36(2):148-156. PubMed ID: 27475894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
